Hara Y et al. |
Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression. |
1994 |
Transplant. Proc. |
pmid:7527955
|
Guy S et al. |
Immunosuppression conversion for relief of side effects. |
1994 |
Transplant. Proc. |
pmid:7527956
|
Knoop C et al. |
FK 506 rescue therapy for irreversible airway rejection in heart-lung transplant recipients: report on five cases. |
1994 |
Transplant. Proc. |
pmid:7527957
|
Candinas D et al. |
Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation. |
1994 |
Transplant. Proc. |
pmid:7527959
|
Iwata H et al. |
Suppression of allograft responses by combining alloantigen-specific i.v. presensitization with suboptimal doses of FK 506 or rapamycin. |
1994 |
Transplant. Proc. |
pmid:7513476
|
Nomoto S et al. |
Cardiotoxicity of long-term intravenous administration of FK506 in rabbits: dose relationship and recovery after discontinuance. |
1994 |
Transplant. Proc. |
pmid:7513477
|
Kato H et al. |
Spontaneous proliferation of peripheral blood mononuclear cells as an indicator for insufficient plasma levels of FK 506 in the early phase after liver transplantation. |
1994 |
Transplant. Proc. |
pmid:7513481
|
Nishikawa K et al. |
Experimental studies of vascularized joint allografts in rats. |
1994 |
Transplant. Proc. |
pmid:7513482
|
Douglas CM et al. |
The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-beta-D-glucan synthase. |
1994 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7528927
|
Lhoëst G et al. |
Isolation and identification of a FK-506 C36-C37 dihydrodiol from erythromycin-induced rabbit liver microsomes. |
1994 |
J Pharm Biomed Anal |
pmid:7516189
|
Kraus-Friedmann N and Feng L |
Reduction of ryanodine binding and cytosolic Ca2+ levels in liver by the immunosuppressant FK506. |
1994 |
Biochem. Pharmacol. |
pmid:7529023
|
Ohtsuka S et al. |
Experimental rat pancreas transplant: surgical technique and immunological considerations. |
1994 |
Surg. Today |
pmid:7516209
|
Hisatomi K et al. |
Limited effectiveness of FK506 administration for ongoing rejection in heterotopic rat heart transplantation. |
1994 |
Surg. Today |
pmid:7516210
|
Wolter K et al. |
Interaction between FK 506 and clarithromycin in a renal transplant patient. |
1994 |
Eur. J. Clin. Pharmacol. |
pmid:7532134
|
Konishi M et al. |
Effects of FK506 on surface antigen expression by regenerating thymocytes after sublethal irradiation in the rat. |
1994 |
Thymus |
pmid:7532330
|
Ohtsuka S et al. |
Mechanism of antibody production in guinea pig to rat discordant xenotransplant: establishment of a simple model by intravenous injection of discordant splenocytes. |
1994 |
Transplant. Proc. |
pmid:7518130
|
Todo S et al. |
Intestinal transplantation at the University of Pittsburgh. |
1994 |
Transplant. Proc. |
pmid:7518136
|
Reyes J et al. |
Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. |
1994 |
Transplant. Proc. |
pmid:7518137
|
Murase N et al. |
Small bowel transplantation in sensitized recipients: comparison with heart, kidney, and liver grafts. |
1994 |
Transplant. Proc. |
pmid:7518139
|
Pruschy MN et al. |
Mechanistic studies of a signaling pathway activated by the organic dimerizer FK1012. |
1994 |
Chem. Biol. |
pmid:9383386
|
Dumont FJ et al. |
Quantitative and temporal analysis of the cellular interaction of FK-506 and rapamycin in T-lymphocytes. |
1994 |
J. Pharmacol. Exp. Ther. |
pmid:7507994
|
Mueller AR et al. |
Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506. |
1994 |
Transplantation |
pmid:7518974
|
Platz KP et al. |
Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506. |
1994 |
Transplantation |
pmid:7518975
|
Cakaloglu Y et al. |
Importance of cytochrome P-450IIIA activity in determining dosage and blood levels of FK 506 and cyclosporine in liver transplant recipients. |
1994 |
Hepatology |
pmid:7519161
|
Luan S et al. |
Light-regulated, tissue-specific immunophilins in a higher plant. |
1994 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7508125
|
Blazar BR et al. |
FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation. |
1994 |
J. Immunol. |
pmid:7519216
|
Tze WJ et al. |
Successful islet allotransplantation in diabetic rats immunosuppressed with FK506: a functional and immunological study. |
1994 |
Metab. Clin. Exp. |
pmid:7510012
|
Yamauchi T |
[Multiple abdominal organ transplantation in swine using FK-506]. |
1994 |
Nihon Geka Gakkai Zasshi |
pmid:7510015
|
Hara Y et al. |
Heterotopic rat heart transplantation to the iliac vessels. |
1994 |
Transplant. Proc. |
pmid:7520632
|
Nozaki S et al. |
Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients. |
1994 |
Transplant. Proc. |
pmid:7520633
|
Masaoka T |
Problems of bone marrow transplantation in Japan. |
1994 |
Transplant. Proc. |
pmid:7520634
|
Surdacka E et al. |
[New immunosuppressive drugs in transplantation]. |
1994 |
Prz. Lek. |
pmid:7532870
|
D'Ambrosio R et al. |
Multicenter comparison of tacrolimus (FK 506) whole blood concentrations as measured by the Abbott IMX analyzer and enzyme immunoassay with methylene chloride extraction. |
1994 |
Ther Drug Monit |
pmid:7521979
|
Metcalfe S et al. |
FK506 and cyclosporin A each inhibit antigen-specific signaling in the T cell line 171 in the absence of a calcium signal. |
1994 |
Cell. Immunol. |
pmid:7522130
|
Calne RY |
Immunosuppression in liver transplantation. |
1994 |
N. Engl. J. Med. |
pmid:7523947
|
Schleuning M et al. |
Inhibition of cyclosporin A/FK506 resistant, lymphokine-induced T-cell activation by phenothiazine derivatives. |
1994 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:7523957
|
Perotti BY et al. |
HPLC assay for FK 506 and two metabolites in isolated rat hepatocytes and rat liver microsomes. |
1994 |
Pharm. Res. |
pmid:7524055
|
Cullen BR and Heitman J |
Human immunodeficiency virus. Chaperoning a pathogen. |
1994 |
Nature |
pmid:7526224
|
Connolly JO et al. |
Renal arteriopathy associated with FK 506 therapy following liver transplantation. |
1994 |
Nephrol. Dial. Transplant. |
pmid:7526278
|
Pham SM et al. |
Cardiac transplantation at the University of Pittsburgh: 1994 update. |
1994 |
Clin Transpl |
pmid:7547531
|
Radanyi C et al. |
The ability of the immunophilin FKBP59-HBI to interact with the 90-kDa heat shock protein is encoded by its tetratricopeptide repeat domain. |
1994 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7526392
|
Abu-Elmagd K et al. |
Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience. |
1994 |
Clin Transpl |
pmid:7547533
|
Ericzon B et al. |
Glucose metabolism in liver transplant recipients treated with FK 506 or cyclosporin in the European multicentre study. |
1994 |
Transpl. Int. |
pmid:11271178
|
Ko S et al. |
The pharmacokinetic benefits of newly developed liposome-incorporated FK506. |
1994 |
Transplantation |
pmid:7526494
|
Shapiro R et al. |
Renal transplantation at the University of Pittsburgh: the impact of FK506. |
1994 |
Clin Transpl |
pmid:7547544
|
Undre N and Möller A |
Pharmacokinetic interpretation of FK 506 levels in blood and in plasma during a European randomised study in primary liver transplant patients. The FK 506 European Study Group. |
1994 |
Transpl. Int. |
pmid:11271189
|
Bendahan J et al. |
The effect of administration of FK506 on delayed regeneration in flushed partially hepatectomized livers. |
1994 |
Transplantation |
pmid:7511255
|
Chavin KD et al. |
Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance. |
1994 |
Transplantation |
pmid:7511258
|
Yano S et al. |
Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes. |
1994 |
Jpn. J. Cancer Res. |
pmid:7511575
|
Iwata H et al. |
Suppression of allograft responses by combining alloantigen-specific i.v. pre-sensitization with suboptimal doses of rapamycin. |
1994 |
Int. Immunol. |
pmid:7511931
|